loader
Anthem Biosciences Limited IPO
Issue Size (Net)
up to Rs.3,395.00 Cr
Price Band
Rs.540 to Rs.570 per share
Issue Opens
July 14, 2025
Issue Closes
July 16, 2025

Company Highlights

1. Company Information

Incorporated in 2006, Anthem Biosciences Limited is an innovation-driven and technology-focused Contract Research, Development, and Manufacturing Organization (“CRDMO”) with fully integrated operations encompassing drug discovery, development, and manufacturing processes.
The company serves diverse customers, including innovative, emerging biotech firms and large pharmaceutical companies on a global scale.
The company manufactures specialized fermentation-based APIs, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars.

2. Anthem Biosciences IPO Registrar
Kfin Technologies Limited

Phone:04067162222, 04079611000
Email:  anthem.ipo@kfintech.com
Website: https://kosmic.kfintech.com 

Anthem Biosciences Limited Financial Information (Restated)

Period Ended
Total Assets
Total Revenue
Profit After Tax
EBITDA
Net Worth
Reserves and Surplus
Total Borrowing
31-Mar-25
2,807.58
1,930.29
451.26
683.78
2,409.86
2,298.05
108.95
31-Mar-24
2,398.11
1,483.07
367.31
519.96
1,924.66
1,815.39
232.53
31-Mar-23
2,014.46
1,133.99
385.19
446.05
1,740.67
1,628.88
125.06
Amount in Rs. Crore

Anthem Biosciences IPO Details

Issue Opening Date
July 14, 2025 
Issue Closing Date
July 16, 2025
Face Value
Rs.2 per share
Price
Rs.540 to Rs.570 per share
Lot Size
26 Shares
Sale Type
Offer For Sale
Total Issue Size
5,95,61,404 shares(aggregating up to Rs.3,395.00 Cr)
Employee Discount
Rs.50.00
Issue Type
Bookbuilding IPO
Listing At
BSE, NSE

Anthem Biosciences IPO Timeline (Tentative Schedule)

Event
Tentative Date
Opening Date
Mon, July 14, 2025
Closing Date
Wed, July 16, 2025
Tentative Allotment
Thu, July 17, 2025
Initiation of Refunds
Fri, July 18, 2025
Credit of Shares to Demat
Fri, July 18, 2025
Listing Date
Mon, July 21, 2025
Cut-off time for UPI mandate confirmation
5 PM on July 16, 2025

Prospectus

Prospectus File

RR Investors Capital Services Pvt. Ltd AMFI-registered Mutual Fund Distributor

ARN-0032 Validity 14-Mar-2027

Head Office - 4th floor, Indraprakash Building 21, Barakhamba Road, New Delhi – 110001

callLandline Number
+91 11-4444-1111

Customer Care
+91 9350316010

Security
  • SSL
Follow Us

SEBI Registration No: NSE Cash: INB231219636 | SEBI Registration No: NSE Derivative: INF231219636 | SEBI Registration No: BSE Cash: INB011219632 | SEBI Registration No: MCX-SX: INE261219636 | SEBI Registration No: NSE Currency: INE231219636 | SEBI Registration No: USE: INE271219631 | SEBI Registration No: CDSL: IN-DP-CDSL-3242005 | NCDEX Membership No: 00635 | MCX Membership No: 28850 | NSEL Membership No: 10650 | RBI Registration No: NBFC: N-14.03215 | IRDA Registration Number : CB-066/03 | AMFI Registration No : ARN -0032| SEBI Registration No: Merchant Banker: INM000007508


* Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.


© 2022 RR Investors Capital Services Pvt. Ltd | All Rights Reserved.